We are live on
!
Find out more
ACM
Athyrium Capital Management Portfolio holdings
AUM
$8.69M
1-Year Est. Return
34.58%
This Fund
S&P 500
This Quarter
Est. Return
-7.32%
1 Year Est. Return
-34.58%
3 Year Est. Return
-25.1%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$198M
AUM Growth
-$9.76M
(-4.7%)
Cap. Flow
+$7.91M
Cap. Flow
% of AUM
4%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCTL
Societal CDMO, Inc. Common Stock
SCTL
|
+$7.91M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
BGC
RVM
JDR
DA
KIM
RJTCONH
HSC
HVM
Athyrium Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, Athyrium Capital Management held 3 positions worth $198M, down 4.7% from $208M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Athyrium Capital Management deployed $7.91M of net new capital in Q1 2021, opening 1 new position. Its largest new stake was Societal CDMO, Inc. Common Stock: 2,202,420 shares worth $6.14M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Athyrium Capital Management's largest Q1 2021 buy was Societal CDMO, Inc. Common Stock: 2,202,420 shares worth $6.14M.
- Athyrium Capital Management's ten largest holdings make up 100% of its $198M portfolio in Q1 2021.
- Athyrium Capital Management opened 1 new position and closed 0 in Q1 2021.
- Athyrium Capital Management's portfolio value fell 4.7% quarter-over-quarter to $198M.
Based on Athyrium Capital Management's 13F filing for Q1 2021, filed 17 May 2021.